COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) 2nd WG Meeting
Congress and symposium participations > Congress · 2018
Authors: Gülşah BAYRAKTAR
2018-2018, COST ACTION CA15135 Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig) 2nd WG Meeting, Congress, Attendee, Spain, Tenerife